Pharmacolog i Uppsala AB

Equities

PERP B

SE0019071812

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm Other stock markets 08:23:08 04/06/2024 pm IST			5-day change	1st Jan Change
0.0828 ^SEK	+0.49%		-16.87%	+46.29%

24/04	Perpetua Medical AB Appoints Camilla Lonn as CFO	CI
23/04	Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B	CI

Pharmacolog Receives New Order from Belgium for DrugLog

January 26, 2023 at 03:02 pm IST

Vivalia Health Care group has ordered a DrugLog™ system for immediate installation. Vivalia is a Health Care organization consisting of six hospitals with more than 1600 beds. DrugLog will primarily be used for quality control of chemotherapy preparations and antibodies at the Arlon Hospital in Belgium.

Latest news about Pharmacolog i Uppsala AB

Perpetua Medical AB Appoints Camilla Lonn as CFO	24/04	CI
Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B	23/04	CI
Pharmacolog i Uppsala AB will Change its Name to Perpetua Medical AB	23/04	CI
Pharmacolog i Uppsala AB Announces the Appointment of Anders Hedlund as Interim CEO, Effective from May 1, 2024	04/04	CI
Pharmacolog Announces Resignation of Lars Gusch as CEO, Effective from April 30, 2024	01/03	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the Full Year Ended December 31, 2023	16/02	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	16/02	CI
Pharmacolog AB Terminates the Partnership Agreement with Codonics Inc	14/02	CI
RaySearch Laboratories AB (OM:RAY B) acquired product line Druglog of Pharmacolog AB for SEK 8.5 million.	09/02	CI
Pharmacolog Receives Two DrugLog Orders for Installation in Renews Hospitals in Europe	10/01	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	17/11	CI
Pharmacolog Implements A Strategy with the Main Objective of Carrying Out an Industrial or Financial Sale	13/23/13	CI
Pharmacolog i Uppsala AB Announces New-york-Presbyterian Orders an Additional Wastelog? System	28/23/28	CI
Pharmacolog i Uppsala AB Announces Executive Changes	27/23/27	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	25/23/25	CI
Renowned Hospitals in the US Select Wastelogâ„¢ to Deter Drug Diversion of Controlled Substances	07/23/07	CI
Pharmacolog i Uppsala AB Announces Board Changes	05/23/05	CI
Pharmacolog I Uppsala AB Upgrade Supports International Expansion	27/23/27	CI
Pharmacolog i Uppsala AB Announces New Platform Available for Sale	01/23/01	CI
Pharmacolog i Uppsala AB Appoints Sofia Uhrbom as Interim Chief Financial Officer	24/23/24	CI
Pharmacolog i Uppsala AB Reports Earnings Results for the First Quarter Ended March 31, 2023	17/23/17	CI
Pharmacolog i Uppsala AB Signs Distribution Agreement with B. Braun	04/23/04	CI
Pharmacolog i Uppsala AB Announces CEO Changes	03/23/03	CI
Pharmacolog i Uppsala AB Announces Changes in Board and Management	03/23/03	CI
Pharmacolog i Uppsala AB Announces Björn Varnestigrequests to Be Dismissed from His Position as Chairman of the Board	02/23/02	CI

Chart Pharmacolog i Uppsala AB

Duration

Period

More charts

Company Profile

Perpetua Medical AB (publ), formerly Pharmacolog I Uppsala AB (publ), is a Sweden-based medical technology company that develops systems and solutions which aim to optimize and ensure correct and effective treatment with injectable drugs. The Company provides solutions and products that verifies that drugs and narcotics used in surgery have not been tampered with, its solutions make a vital contribution to preventing drug diversion. Its products Pharmacolog Dashboard offers a variety of valuable tools, generating reports and statistical analyses of validated pharmaceuticals. Another product WasteLog is a device that manages the workflow by instantly analyzing the waste and returns of injectable controlled substances.

Sector

Advanced Medical Equipment & Technology

Calendar

29/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
PHARMACOLOG I UPPSALA AB	+46.29%	860K
QUIDELORTHO CORPORATION	-41.30%	2.9B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+24.32%	1.97B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-8.30%	1.53B
BIOTAGE AB	+27.75%	1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-17.31%	953M
CONTEC MEDICAL SYSTEMS CO.,LTD	-28.65%	817M
REVENIO GROUP OYJ	+2.36%	807M
VAREX IMAGING CORPORATION	-24.15%	635M
CELLAVISION AB	+22.64%	599M

Medical Diagnostic & Testing Equipment